Andrew Luk

Andrew Luk is a highly experienced professional in the fields of pharmaceuticals and medical devices, currently serving as Vice President of Technology Translation and Executive Director of Global Alliance at Pleryon Therapeutics since July 2021. Andrew founded Crestwood Consulting LLC in January 2020, providing expertise in the development of drug/device products. Previously, Andrew held senior roles at CooperVision, Cordis, Johnson & Johnson/ALZA, AstraZeneca, and InSiteVision, leading teams and managing projects focused on drug delivery systems and device innovation. Andrew holds a Ph.D. and a BS in Chemical Engineering from the University of Delaware and New Jersey Institute of Technology, respectively, and has published extensively, including multiple patents and presentations.